Medical Disclaimer:<\/strong>
\nThis content is shared for informational and educational purposes only.
\nIt does not constitute medical, legal, or policy advice.
\nHealthcare decisions should always be made in consultation with qualified professionals.\n<\/p>\n
\n<\/p>\n","protected":false},"excerpt":{"rendered":"
(MedPage Today) — Use of a PCSK9 inhibitor to lower lipid levels was linked with significantly better survival in patients with certain cancers treated with immune checkpoint inhibitors (ICIs), a matched-cohort study showed. Treatment with a… Source: www.medpagetoday.com Medical Disclaimer: This content is shared for informational and educational purposes only. It does not constitute medical, […]<\/p>\n","protected":false},"author":1,"featured_media":39640,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[171],"tags":[1749,13717,20446,11055,12856,22689,13035],"class_list":["post-39639","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-conditions","tag-cancer","tag-immunotherapy","tag-inhibitors","tag-linked","tag-patients","tag-pcsk9","tag-survival"],"jetpack_publicize_connections":[],"_links":{"self":[{"href":"https:\/\/pickbydoc.com\/index.php?rest_route=\/wp\/v2\/posts\/39639","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pickbydoc.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pickbydoc.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pickbydoc.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pickbydoc.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=39639"}],"version-history":[{"count":0,"href":"https:\/\/pickbydoc.com\/index.php?rest_route=\/wp\/v2\/posts\/39639\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pickbydoc.com\/index.php?rest_route=\/wp\/v2\/media\/39640"}],"wp:attachment":[{"href":"https:\/\/pickbydoc.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=39639"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pickbydoc.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=39639"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pickbydoc.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=39639"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![](\"https:\/\/clf1.medpagetoday.com\/media\/images\/121xxx\/121499.jpg\")
(MedPage Today) — Use of a PCSK9 inhibitor to lower lipid levels was linked with significantly better survival in patients with certain cancers treated with immune checkpoint inhibitors (ICIs), a matched-cohort study showed.